A carregar...
Patient-derived glioblastoma stem cells respond differentially to targeted therapies
The dismal prognosis of glioblastoma is, at least in part, attributable to the difficulty in eradicating glioblastoma stem cells (GSCs). However, whether this difficulty is caused by the differential responses of GSCs to drugs remains to be determined. To address this, we isolated and characterized...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349922/ https://ncbi.nlm.nih.gov/pubmed/27863440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13415 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|